The FDA Funding Crisis

  • Judith Alphonse
  • , Sireesha Bellam
  • , Marlene Fernandez
  • , Anishka Gilbert
  • , Lauren Roper
  • , Antonia Zapantis
  • , Robert C Speth
  • , Robert Speth

Research output: Contribution to journalArticlepeer-review

Abstract

The role of the Food and Drug Administration (FDA) is to ensure the safety of prescription and nonprescription drugs, dietary supplements, and the food supply, representing more than 20% of US consumer spending. The increased need to monitor imported drugs, drug products and foods, drug shortages, and compounding pharmacies bring the adequacy of FDA funding into question. Performing even at status quo cannot be accomplished if responsibilities increase without equitable funding increases: both from the federal government and fees imposed on FDA-regulated industries. Additionally, scientific advancement, new legislation, and new industries are continually increasing the FDA workload, necessitating commensurate budget increases.

Original languageAmerican English
Pages (from-to)57-60
Number of pages4
JournalThe Journal of Pharmacy Technology : JPT
Volume30
Issue number2
DOIs
StatePublished - Apr 1 2014

Bibliographical note

© The Author(s) 2013.

Keywords

  • FDA
  • drug compounding
  • funding
  • quality control
  • regulation
  • safety
  • Drug compounding
  • Funding
  • Quality control
  • Regulation
  • Safety

Disciplines

  • Medicine and Health Sciences
  • Pharmacy and Pharmaceutical Sciences

Fingerprint

Dive into the research topics of 'The FDA Funding Crisis'. Together they form a unique fingerprint.

Cite this